$10.360
-0.440 (-4.25%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de OCUL por análisis de gráficos similares
Alphio's OCUL stock price prediction model matches the current Ocular Therapeutix Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.32 (-0.42%). The 1-week path is $10.78 (+4.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Ocular Therapeutix Inc?
Ocular Therapeutix Inc (OCUL) appears to be a good buy right now due to its recent positive trial results and bullish analyst ratings. The stock is currently priced at $10.36, with analysts setting price targets as high as $30, suggesting a potential upside of over 189%. Additionally, the RSI is at 41.34, indicating that the stock is not overbought, and the recent surge in market sentiment following EyePoint's trial failure strengthens OCUL's competitive position. However, the company has reported substantial net losses, with a net income of -78.76 million in Q2 2026, which remains a significant risk to consider.
OCUL cerró en $10.36 el Friday, tras bajar -4.25%
Ocular Therapeutix Inc (OCUL) last closed at $10.36, losing -4.25%. These facts feed the 1-day and 1-week OCUL price prediction above.
Consenso de analistas
Ocular Therapeutix Inc (OCUL): 5 comprar, 2 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Ocular Therapeutix Inc (OCUL) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de OCUL, ordenadas por similitud.
Análisis de estacionalidad de OCUL
Historically the probability of a positive August return for OCUL is 68.25%. September offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de OCUL
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $7.56 | $8.91 | $9.12 | -14.00% |
| Sep 2026 | $5.63 | $7.17 | $8.37 | -30.80% |
| Oct 2026 | $5.81 | $6.65 | $8.63 | -35.77% |
| Nov 2026 | $4.79 | $6.56 | $7.88 | -36.69% |
| Dec 2026 | $4.99 | $6.65 | $8.20 | -35.77% |
En 2026, se proyecta que Ocular Therapeutix Inc (OCUL) oscile entre $4.79 y $9.12.
Previsión mensual de Ocular Therapeutix Inc para 2026
En Aug de 2026, se proyecta que Ocular Therapeutix Inc promedie $8.91, con un mínimo de $7.56 y un máximo de $9.12.
En Sep de 2026, se proyecta que Ocular Therapeutix Inc promedie $7.17, con un mínimo de $5.63 y un máximo de $8.37.
En Oct de 2026, se proyecta que Ocular Therapeutix Inc promedie $6.65, con un mínimo de $5.81 y un máximo de $8.63.
En Nov de 2026, se proyecta que Ocular Therapeutix Inc promedie $6.56, con un mínimo de $4.79 y un máximo de $7.88.
En Dec de 2026, se proyecta que Ocular Therapeutix Inc promedie $6.65, con un mínimo de $4.99 y un máximo de $8.20.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.